West Pharma softens revenue guidance after Q2 results

• West Pharmaceutical Services (NYSE:WST +0.5%) Q2 results: Net Sales: $368.9M (+7.1%), Pharma Packaging Systems: $268.0M (+6.6%), Pharma Delivery Systems: $101.1M (+8.4%); Gross Profit: $121.8M (+9.8%); Operating Income: $54.1M (+27.3%); Net Income: $37.6M (+24.5%); EPS: $0.52 (+20.9%); Quick Assets: $226.7M (-1.4%).
• 2014 Guidance: Net sales: $1.43B - 1.46B from $1.45B - 1.48B; Pharmaceutical Delivery Systems sales: $400M - 410M (unch); Pharmaceutical Packaging Systems sales: $1.03B - 1.05B from $1.05B - 1.07B; EPS: $1.77 - 1.89 (unch);